SentiAR

SentiAR Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $3M
Latest Deal Amount
  • Investors
  • 10

SentiAR General Information

Description

Developer of the first real-time intraprocedural augmented reality platform designed to transform the experience for both patient and clinician in interventional procedures. The company's platform is a 3D augmented reality platform featuring real-time holographic visualization of the patient's actual anatomy, enabling the clinician to offer treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Surgical Devices
Monitoring Equipment
Primary Office
  • 212 Kingshighway Boulevard
  • Suite 115
  • Saint Louis, MO 63108
  • United States
+1 (314) 000-0000

SentiAR Timeline

201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SentiAR Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series A) 23-Mar-2020 $3M 00.000 000.00 Completed Pre-Clinical Trials
5. Seed Round 16-Apr-2018 000 Completed Pre-Clinical Trials
4. Early Stage VC (Series A) 22-Feb-2018 000 Cancelled Pre-Clinical Trials
3. Grant 15-Jan-2018 00.00 Completed Product In Beta Test
2. Grant 03-Nov-2017 $595K Completed Product In Beta Test
1. Seed Round 31-Aug-2017 $1.1M Completed Product In Beta Test

SentiAR Cap Table

To view SentiAR‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A-3 000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A-2 658,080 $0.000010 6% $1.67 $1.67 1x $1.67 14.29%
Series A-1 157,042 $0.000010 6% $1.91 $1.91 1x $1.91 3.41%

SentiAR Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
RealView Imaging Venture Capital-Backed Yokneam, Israel 00 0000 0000000000 0 0000
00000000 0000000 Venture Capital-Backed Cleveland, OH 00 000.00 0000000000 0 000.00
000000000 Venture Capital-Backed Arlington Heights, IL 00 000.00 00000000000 000.00
000000000 Venture Capital-Backed Santa Clara, CA 00 000.00 00000000000 000.00

SentiAR Executive Team (5)

Name Title Board Seat Contact Info
Berk Tas Chief Executive Officer, President & Board Member
Jonathan Silva Co-Founder, Chief Technology Officer & Board Member
Michael Southworth Co-Founder & Vice President, Technology
Jennifer Silva MD Co-Founder, Chief Medical Officer & Board Member

1 Former Executive

SentiAR Board Members (6)

To view SentiAR‘s full board member team, request access »
Name Representing Role Since
Berk Tas SentiAR Chief Executive Officer, President & Board Member 000 0000
Charles Bolten BioGenerator Board Member 000 0000
Jennifer Silva MD SentiAR Co-Founder, Chief Medical Officer & Board Member 000 0000
Jonathan Silva SentiAR Co-Founder, Chief Technology Officer & Board Member 000 0000
William Schmidt Cultivation Capital Board Member 000 0000

1 Former Board Member

SentiAR Investors (10)

To view SentiAR‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Neue Fund Venture Capital Minority 000 0000 000000 0
VCapital Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
Arch Grants Not-For-Profit Venture Capital 000 0000 000000 0
Children's Discovery Institute Other 000 0000 000000 0

Ready to get started?

Request a free trial